TrademarkOpen
Search / US trademark / 99764770
US trademark

SOFMEREE

Allowed — statement of use stage
Notice Of Allowance - Issued

Status timeline

  1. 15 Apr 2026
    Application filed
    New Application Entered
  2. 12 May 2026
    Assigned to an examining attorney
    Assigned To Examiner
  3. 14 May 2026
    Approved for publication
    Approved For Pub - Principal Register
  4. 9 Jun 2026
    Published for opposition
    Published For Opposition
  5. 4 Aug 2026
    Notice of allowance issued — statement of use required
    Noa E-Mailed - Sou Required From Applicant
All 9 USPTO events
2026-08-04Noa E-Mailed - Sou Required From Applicant
2026-06-09Published For Opposition
2026-06-09Official Gazette Publication Confirmation E-Mailed
2026-06-03Notification Of Notice Of Publication E-Mailed
2026-05-14Approved For Pub - Principal Register
2026-05-12Assigned To Examiner
2026-04-15New Application Entered
2026-04-15New Application Office Supplied Data Entered
2026-04-15Application Filing Receipt Mailed

Goods & services

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, m…

Source & freshness

Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 4 Aug 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.